The contribution of HIV point-of-care tests in early HIV diagnosis: community-based HIV testing monitoring in Catalonia, 1995 to 2018.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 30 10 2020
pubmed: 31 10 2020
medline: 25 2 2021
Statut: ppublish

Résumé

BackgroundCommunity-based HIV testing services combined with the use of point-of-care tests (POCT) have the potential to improve early diagnosis through increasing availability, accessibility and uptake of HIV testing.AimTo describe community-based HIV testing activity in Catalonia, Spain, from 1995 to 2018, and to evaluate the impact of HIV POCT on the HIV continuum of care.MethodsA community-based network of voluntary counselling and testing services in Catalonia, Spain has been collecting systematic data on activity, process and results since 1995. A descriptive analysis was performed on pooled data, describing the data in terms of people tested and reactive screening test results.ResultsBetween 1995 and 2018, 125,876 HIV tests were performed (2.1% reactive). Since the introduction of HIV POCT in 2007, a large increase in the number of tests performed was observed, reaching 14,537 tests alone in 2018 (1.3% reactive). Men who have sex with men (MSM), as a proportion of all people tested, has increased greatly over time reaching 74.7% in 2018. The highest percentage of reactive tests was found in people who inject drugs followed by MSM. The contribution of community-based HIV testing to the overall total notified cases in the Catalonia HIV registry has gradually increased, reaching 37.9% in 2018, and 70% of all MSM cases. In 2018, the percentage of individuals with a reactive screening test who were linked to care was 89.0%.ConclusionOur study reinforces the important role that community-based HIV POCT has on the diagnosis of HIV in key populations.

Identifiants

pubmed: 33124552
doi: 10.2807/1560-7917.ES.2020.25.43.1900424
pmc: PMC7596919
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2016 Dec 1;21(48):
pubmed: 27934584
BMJ Open. 2014 Dec 15;4(12):e006859
pubmed: 25510889
Int J STD AIDS. 2010 Jun;21(6):388-91
pubmed: 20606218
J Clin Microbiol. 2008 Dec;46(12):3946-51
pubmed: 18923015
BMJ Open. 2018 Feb 28;8(2):e018533
pubmed: 29490955
AIDS Care. 2016;28 Suppl 1:32-6
pubmed: 26883807
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
PLoS Med. 2013 Aug;10(8):e1001496
pubmed: 23966838
Euro Surveill. 2017 Nov;22(48):
pubmed: 29208158
PLoS One. 2018 Feb 16;13(2):e0192403
pubmed: 29451875
HIV Med. 2015 May;16(5):280-7
pubmed: 25604470
Lancet HIV. 2017 Nov;4(11):e482-e483
pubmed: 29066095
PLoS One. 2015 Apr 21;10(4):e0123814
pubmed: 25898140
HIV Med. 2018 Feb;19 Suppl 1:21-26
pubmed: 29488701
Sex Transm Infect. 2006 Dec;82 Suppl 5:v1-6
pubmed: 17151023
AIDS Care. 2016;28(6):712-6
pubmed: 27007000

Auteurs

Laura Fernàndez-López (L)

Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Health Department, Barcelona, Spain.
Centros de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Spain.

Juliana Reyes-Urueña (J)

Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Health Department, Barcelona, Spain.
Centros de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Spain.

Anna Conway (A)

Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Health Department, Barcelona, Spain.
The Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.

Jorge Saz (J)

BCN Checkpoint, Barcelona, Spain.

Adriana Morales (A)

Stop Sida, Barcelona, Spain.

Jaime Quezadas (J)

Associació Ciutadana Antisida de Catalunya (ACASC), Barcelona, Spain.

Jordi Baroja (J)

Centre Jove d'Atenció a les Sexualitats (CJAS), Barcelona, Spain.

Anna Rafel (A)

Associació Antisida de Lleida, Lleida, Spain.

Ander Pazos (A)

Gais Positius, Barcelona, Spain.

Anna Avellaneda (A)

Actuavallès, Sabadell, Spain.

Mercè Meroño (M)

Fundació Àmbit Prevenció, Barcelona, Spain.

Lorena Andreo (L)

CAS/ARD Lluís Companys, Creu Roja Barcelona, Barcelona, Spain.

Lluís Romero (L)

Assexora'Tgn (Associacio Comunitària de Salut Sexual del Camp de Tarragona), Tarragona, Spain.

Anna Lara (A)

Associació Comunitària Anti Sida de Girona (ACAS), Girona, Spain.

Araceli Otón (A)

Creu Roja Tarragona, Tarragona, Spain.

Benet Rifà (B)

Section for Surveillance, Prevention and Control of Sexually Transmitted Infections and HIV, Public Health Agency of Catalonia, Barcelona, Spain.
Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis, Public Health Agency of Catalonia, Barcelona, Spain.

Rosa Mansilla (R)

Section for Surveillance, Prevention and Control of Sexually Transmitted Infections and HIV, Public Health Agency of Catalonia, Barcelona, Spain.
Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis, Public Health Agency of Catalonia, Barcelona, Spain.

Joan Colom (J)

Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis, Public Health Agency of Catalonia, Barcelona, Spain.

Jordi Casabona (J)

Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Health Department, Barcelona, Spain.
Department of Paediatrics, Obstetrics and Gynaecology, and Preventive Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Centros de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH